Dear Colleagues,

Following the success of the first edition of “Reproductive Health Concerns for Women”, we are pleased to announce this continuation.

I am pleased to inform you all that the first edition, which focused on reproductive health concerns for women, closed successfully with 11 publications. I appreciate all of your manuscripts, which enriched the basic understanding and advanced the knowledge of this field. As shown in the first edition, women of reproductive age are living in the most nourished and productive period of life. Generally, they are spirited and healthy. However, there is no doubt that many hormone-related disorders and fertility-related problems are apparent in this period. These include inflammatory diseases, menstruation-related disorders, sub- or infertility problems, pregnancy-related diseases, and various kinds of benign and/or malignant genito-urinary tract tumors. The preservation of reproductive function is of paramount importance for these women, contributing to a significant and big challenge in modern medicine. A better understanding of the pathophysiology of these disorders and the continuous development of far-advanced new technology in the screening, monitoring, and managing of these disorders not only provide a better chance in the successful treatment for these disorders but also for maintaining the anatomical and functional integrity in women. For example, with the aid of minimally invasive surgery and the combination of more effective medications in uterine fibroids, women can be managed conservatively with functional organ preservation in place of hysterectomy. In addition, assisted reproductive technology significantly helps many infertile couples to have their families.

We would like to invite all experts to contribute to this field. Extensive systematic reviews and meta-analyses, as well as original research ranging from the bench to clinical management, are all welcome. Let us work together to do something positive for our world.

Prof. Dr. Peng-Hui Wang
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• fertility preservation
• fertility-sparing surgery
• benign or malignant gynecological diseases
• infertility
• health promotion
• safe pregnancy

• Reproductive Health Concerns for Women in Life (12 articles)